Lipocine Inc (LPCN)

09:33 AM

How Lipocine Inc. stock benefits from strong dollarWeekly Risk Report & Safe Capital Growth Trade Ideas - ulpravda.ru

09:33 AM

Jan 06, 2026

How Lipocine Inc. stock reacts to global recession fears2026 world cup usa national team round of 16 young talents high defensive line expert forecast preview - ulpravda.ru

Jan 06, 2026

Dec 26, 2025

Critical Review: Lipocine (NASDAQ:LPCN) & Lyell Immunopharma (NASDAQ:LYEL) - Defense World

Dec 26, 2025

Dec 24, 2025

Lipocine reports ‘promising’ safety profile in Phase 3 trial of LPCN 1154 - MSN

Dec 24, 2025

Dec 24, 2025

Lipocine price target lowered to $7 from $8 at H.C. Wainwright - MSN

Dec 24, 2025

Dec 21, 2025

Aug PreEarnings: Can Lipocine Inc. stock outperform in 2025 bull marketQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - Улправда

Dec 21, 2025

Dec 21, 2025

Market Pulse: How Lipocine Inc. stock reacts to global recession fearsWeekly Trade Report & Long Hold Capital Preservation Tips - Улправда

Dec 21, 2025

Dec 20, 2025

Can Lipocine Inc. stock outperform in 2025 bull marketMarket Sentiment Report & Weekly High Return Stock Opportunities - Улправда

Dec 20, 2025

Dec 19, 2025

Does Lipocine Inc. stock trade at a discount to peersJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - Улправда

Dec 19, 2025

Dec 19, 2025

Return on equity % of Lipocine Inc. – BOATS:LPCN - TradingView — Track All Markets

Dec 19, 2025

Dec 19, 2025

Trend Review: Can Lipocine Inc. stock deliver consistent earnings growth2025 Valuation Update & Detailed Earnings Play Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Lipocine Inc. stock performs in high volatility marketsJuly 2025 Snapshot & Fast Gain Stock Trading Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Financial Review: Lipocine (NASDAQ:LPCN) vs. Astellas Pharma (OTCMKTS:ALPMY) - Defense World

Dec 19, 2025

Dec 16, 2025

Lipocine reaches 80% enrollment in postpartum depression drug trial By Investing.com - Investing.com Nigeria

Dec 16, 2025

Dec 16, 2025

Lipocine Advances Phase 3 Trial for PPD Treatment - TipRanks

Dec 16, 2025

Dec 16, 2025

Lipocine Inc Announces 80% Enrollment in PPD Phase 3 Study - TradingView — Track All Markets

Dec 16, 2025

Dec 16, 2025

Lipocine reaches 80% enrollment in postpartum depression drug trial - Investing.com India

Dec 16, 2025

Dec 16, 2025

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone - PR Newswire

Dec 16, 2025

Dec 15, 2025

Lipocine Inc. Announces Resignation of Jeffrey Fink as Director, Effective January 1, 2026 - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Lipocine Earnings Notes - Trefis

Dec 15, 2025

Dec 11, 2025

Lipocine presents LPCN 2101 epilepsy candidate data at annual AES meeting - Investing.com UK

Dec 11, 2025

Dec 03, 2025

EBIT per share of Lipocine Inc. – BOATS:LPCN - TradingView

Dec 03, 2025

Dec 01, 2025

Lipocine (LPCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 23, 2025

Lipocine Inc. (LPCN) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 23, 2025

Nov 21, 2025

Why hedge funds are buying Lipocine Inc. stockPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com

Nov 21, 2025

Nov 20, 2025

Can Lipocine Inc. stock sustain revenue growthJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com

Nov 20, 2025

Nov 20, 2025

Will Lipocine Inc. stock outperform value stocksMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com

Nov 20, 2025

Nov 19, 2025

Can Lipocine Inc. stock resist sector downturnsJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

How Lipocine Inc. stock reacts to inflationary pressuresOptions Play & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Smart tools for monitoring Lipocine Inc.’s price actionEarnings Summary Report & Community Driven Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Lipocine Inc. stock a safe buy before earningsQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025

Nov 18, 2025

Lipocine reports positive safety review for PPD treatment in phase 3 trial - Investing.com Nigeria

Nov 18, 2025

Nov 18, 2025

Lipocine Announces Positive Interim Results for PPD Trial - TipRanks

Nov 18, 2025

Nov 18, 2025

[8-K] Lipocine Inc. Reports Material Event | LPCN SEC FilingForm 8-K - Stock Titan

Nov 18, 2025

Nov 18, 2025

Lipocine highlights promising interim safety profile in phase 3 trial of LPCN 1154 in postpartum depression (PPD) - MarketScreener

Nov 18, 2025